vs
STANDARD BIOTOOLS INC.（LAB）与SIEBERT FINANCIAL CORP（SIEB）财务数据对比。点击上方公司名可切换其他公司
SIEBERT FINANCIAL CORP的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$23.6M vs $19.6M），SIEBERT FINANCIAL CORP净利率更高（-1.9% vs -177.4%，领先175.5%），SIEBERT FINANCIAL CORP同比增速更快（17.7% vs -11.5%），SIEBERT FINANCIAL CORP自由现金流更多（$9.7M vs $-23.1M），过去两年SIEBERT FINANCIAL CORP的营收复合增速更高（7.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
西伯特金融公司是总部位于美国的金融服务供应商，主营折扣经纪业务，为零售及机构客户提供自助投资工具、退休账户解决方案和财富管理咨询服务，专注为个人投资者提供高性价比的普惠投资选择。
LAB vs SIEB — 直观对比
营收规模更大
SIEB
是对方的1.2倍
$19.6M
营收增速更快
SIEB
高出29.2%
-11.5%
净利率更高
SIEB
高出175.5%
-177.4%
自由现金流更多
SIEB
多$32.8M
$-23.1M
两年增速更快
SIEB
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $23.6M |
| 净利润 | $-34.7M | $-445.0K |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -5.5% |
| 净利率 | -177.4% | -1.9% |
| 营收同比 | -11.5% | 17.7% |
| 净利润同比 | -28.8% | -125.6% |
| 每股收益（稀释后） | $-0.09 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABSIEB
| Q4 25 | — | $23.6M | ||
| Q3 25 | $19.6M | $26.8M | ||
| Q2 25 | $21.8M | $14.9M | ||
| Q1 25 | $40.8M | $28.9M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | $22.1M | $22.6M | ||
| Q2 24 | $22.5M | $20.9M | ||
| Q1 24 | $45.5M | $20.5M |
净利润LABSIEB
| Q4 25 | — | $-445.0K | ||
| Q3 25 | $-34.7M | $1.6M | ||
| Q2 25 | $-33.5M | $-4.7M | ||
| Q1 25 | $-26.0M | $8.7M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-26.9M | $3.8M | ||
| Q2 24 | $-45.7M | $4.0M | ||
| Q1 24 | $-32.2M | $3.7M |
毛利率LABSIEB
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABSIEB
| Q4 25 | — | -5.5% | ||
| Q3 25 | -168.5% | 8.1% | ||
| Q2 25 | -118.1% | -39.2% | ||
| Q1 25 | -80.8% | 36.3% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -120.9% | 21.4% | ||
| Q2 24 | -134.5% | 26.7% | ||
| Q1 24 | -132.2% | 24.9% |
净利率LABSIEB
| Q4 25 | — | -1.9% | ||
| Q3 25 | -177.4% | 6.0% | ||
| Q2 25 | -153.7% | -31.7% | ||
| Q1 25 | -63.8% | 29.9% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | -122.0% | 17.0% | ||
| Q2 24 | -203.3% | 19.4% | ||
| Q1 24 | -70.6% | 18.0% |
每股收益（稀释后）LABSIEB
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.09 | $0.04 | ||
| Q2 25 | $-0.09 | $-0.12 | ||
| Q1 25 | $-0.07 | $0.22 | ||
| Q4 24 | — | $0.04 | ||
| Q3 24 | $-0.07 | $0.10 | ||
| Q2 24 | $-0.12 | $0.10 | ||
| Q1 24 | $-0.27 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $22.4M |
| 总债务越低越好 | — | $4.1M |
| 股东权益账面价值 | $399.7M | $89.2M |
| 总资产 | $539.6M | $759.0M |
| 负债/权益比越低杠杆越低 | — | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资LABSIEB
| Q4 25 | — | $22.4M | ||
| Q3 25 | $129.4M | $19.6M | ||
| Q2 25 | $158.6M | $28.9M | ||
| Q1 25 | $150.9M | $25.7M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $210.6M | $4.4M | ||
| Q2 24 | $269.8M | $5.2M | ||
| Q1 24 | $287.1M | $2.9M |
总债务LABSIEB
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $4.2M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $55.2M | $4.2M | ||
| Q2 24 | $55.1M | $4.3M | ||
| Q1 24 | $55.0M | $4.3M |
股东权益LABSIEB
| Q4 25 | — | $89.2M | ||
| Q3 25 | $399.7M | $90.9M | ||
| Q2 25 | $424.5M | $89.0M | ||
| Q1 25 | $454.6M | $93.3M | ||
| Q4 24 | — | $84.1M | ||
| Q3 24 | $489.3M | $82.3M | ||
| Q2 24 | $510.3M | $78.2M | ||
| Q1 24 | $577.3M | $73.8M |
总资产LABSIEB
| Q4 25 | — | $759.0M | ||
| Q3 25 | $539.6M | $607.5M | ||
| Q2 25 | $557.0M | $560.5M | ||
| Q1 25 | $579.6M | $534.2M | ||
| Q4 24 | — | $519.7M | ||
| Q3 24 | $681.5M | $579.2M | ||
| Q2 24 | $708.7M | $609.1M | ||
| Q1 24 | $777.7M | $742.3M |
负债/权益比LABSIEB
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.05× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | 0.11× | 0.05× | ||
| Q2 24 | 0.11× | 0.05× | ||
| Q1 24 | 0.10× | 0.06× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $10.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $9.7M |
| 自由现金流率自由现金流/营收 | -118.1% | 41.1% |
| 资本支出强度资本支出/营收 | 4.5% | 2.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $19.1M |
8季度趋势，按日历期对齐
经营现金流LABSIEB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-22.2M | $43.7M | ||
| Q2 25 | $-20.7M | $631.0K | ||
| Q1 25 | $-30.3M | $-34.5M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $-27.9M | $3.0M | ||
| Q2 24 | $-39.0M | $18.6M | ||
| Q1 24 | $-62.5M | $-47.0M |
自由现金流LABSIEB
| Q4 25 | — | $9.7M | ||
| Q3 25 | $-23.1M | $43.3M | ||
| Q2 25 | $-22.6M | $570.0K | ||
| Q1 25 | $-35.3M | $-34.5M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | $18.6M | ||
| Q1 24 | $-63.3M | $-47.0M |
自由现金流率LABSIEB
| Q4 25 | — | 41.1% | ||
| Q3 25 | -118.1% | 161.5% | ||
| Q2 25 | -103.6% | 3.8% | ||
| Q1 25 | -86.6% | -119.4% | ||
| Q4 24 | — | 49.1% | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | 89.0% | ||
| Q1 24 | -138.9% | -229.7% |
资本支出强度LABSIEB
| Q4 25 | — | 2.3% | ||
| Q3 25 | 4.5% | 1.2% | ||
| Q2 25 | 8.7% | 0.4% | ||
| Q1 25 | 12.4% | 0.2% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | 10.2% | 0.0% | ||
| Q2 24 | 8.6% | 0.2% | ||
| Q1 24 | 1.7% | 0.1% |
现金转化率LABSIEB
| Q4 25 | — | — | ||
| Q3 25 | — | 26.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.98× | ||
| Q4 24 | — | 5.79× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 4.60× | ||
| Q1 24 | — | -12.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SIEB
| Margin Interest | $14.0M | 59% |
| Other Incomes | $3.6M | 15% |
| Proprietary Trading | $2.6M | 11% |
| Market Making | $2.2M | 9% |
| Media Sports And Entertainment | $1.2M | 5% |
